Introduction

CD4
+ T cells are usually described as « helper » cells. They have a major role in controlling and regulating the immune system by providing help for B-cell activation and generation of cytotoxic CD8 + T cells [13, 14] . According to functional properties and cytokine secretion profiles, CD4 + T cells are grouped into different subsets that provide a homeostatic balance between pro and anti-inflammatory responses. Helper T cells heterogeneity was first discovered two decades ago with the description of T H 1 and T H 2 cells [13, 14] . T H 1 cells are involved in host defense against intracellular pathogens and tumor cells by producing high levels of IFN-γ, TNF-α and IL-2. T H 2 cells are responsible for coordinating humoral immunity, eosinophilic inflammation and are involved in host defense against extracellular parasites by secreting IL-4, IL-5, IL-10 and IL-13. New distinct subsets (T H 9, T H 22, T H 17, T H FH, NKT, Treg cells) have been described confirming the heterogeneity of the CD4 + T cell family [15, 16] . Several studies in mice and humans have reported a cytotoxic potential of CD4 + T cells. These initial observations have usually been restricted to cell lines and CD4 + T cell clones generated by in vitro culture [17] [18] [19] [20] . The cytotoxic activity of CD4 + T cells has therefore often been considered as an artefact [21] . However, recent reports described CD4 + cytotoxic T cells (CTL) in peripheral blood, i.e. ex vivo, in various human pathologies such as Human Immunodeficiency Virus (HIV) [22] , Cytomegalovirus (CMV) [23] , poxvirus [24] , Influenza [25] and Epstein -Barr virus (EBV) infections [26] , B-cell chronic lymphocytic leukemia [27] and rheumatoid arthritis [28] . Healthy individuals have few CD4 + CTLs, representing 2% of the whole CD4 + T cell population. This percentage is markedly increased in HIV infection, with up to 50% of CD4 + T cells exhibiting a cytotoxic potential [22, 29] . Moreover, cytolysis of virally infected cells by CD4 + T cells has been observed in vivo in lymphochoriomeningitis virus (LCMV) [30] and gamma-herpes virus [31] infected mice. CD4 + CTLs could represent a novel CD4 + subset with a unique lineage and functionality. The immune activation may thus be a major factor driving CD4 + T cell differentiation and promoting the acquisition of lytic properties [32] [33] [34] [35] .
Brucella is an intracellular bacterial pathogen that causes abortion and infertility in mammals and leads to a debilitating febrile illness that can progress into a long severe complications in humans [1] . Brucella species are closely related and display very similar pathogenic behavior, although they vary in their virulence and host affinity. For humans, the most pathogenic species are Brucella melitensis, Brucella abortus and Brucella suis [2] . Immune response to Brucella infection depends on the host, species or strain of Brucella and environment [3] . Moreover due to practical, economical and ethical reasons, studying brucellosis in natural hosts is difficult. In this context, mouse models have been widely used and have provided important mechanistic insights into the understanding of immune response against virulent Brucella [4, 5] .
Although innate immunity is capable of controlling Brucella replication during the acute phase in mice, effective adaptive immunity is necessary to mount a strong immune response at later stages of infection [6, 7] . It has been largely described that IFN-γ-mediated T H 1 responses are essential for the clearance of the pathogen [6] . Indeed, IFN-γ produced by CD4 + T cells and γδ T cells have recently been shown to activate the bactericidal properties in macrophages to hamper Brucella intra-host survival whereas IFN-γ produced by CD8 + T cells and B cell-related humoral immunity are modest players against Brucella infection in mice [8, 9] although it has been demonstrated that T H 1-type antibody isotypes such as IgG2a and IgG3, opsonize Brucella to facilitate phagocytosis and bacterial delivery into degradative endocytic compartments [10] . In humans, IFN-γ producing CD4 + T cells, CD8 + T cells and γδ T cells have been implicated in the control of brucellosis [11, 12] .
In Brucella infection it has been proposed that CD4 + T cells display a cytotoxic potential upon Brucella vaccination [36] and it has been shown that perforin -/-mice have a decreased ability to control B. abortus replication at early stages of infection [7] .
Here we have studied cell-mediated adaptive immune responses during Brucella abortus infection. We have identified CD4 + CTLs in the mouse model of virulent B. abortus infection. CD4 + CTLs produce high levels of cytotoxic factor Granzyme B, express immunophenotypic features consistent with fully differentiated T cells and display cytolytic activity against infected phagocytes. We propose that CD4+ CTLs represent an immune cell-subtype triggered by early immune responses upon Brucella abortus infection. 
Results
Identification of GranzymeB
T cells upon Brucella infection
To study the cellular immune responses generated during Brucella infection we examined CD4 + and CD8 + T cell activation at several time points post-infection by measuring the surface expression of CD25, CD44 and the intracellular synthesis of effector molecules such as Granzyme B and IFN-γ. At 5 days post-infection, the CD8 + T cell population in the spleen expressed high levels of Granzyme B ( Figure 1 ) and was able to synthesize IFN-γ ( Figure 1A and C). Interestingly, Granzyme B expression was also observed in 20% of CD4 + T cells (Figure 1 ). Cellular immune responses were even more pronounced at 8 days post-infection. Approximately 80% of the CD8 + T cell population expressed Granzyme B and strikingly almost the entire CD4 + T cell population was positive for Granzyme B ( Figure 1A and B), 20% of which synthesized IFN-γ ( Figure 1A and C) . The percentage of Granzyme B-positive CD4 + varied between 70-90% depending on experiments (Figures 1 and 2) . This is the first in vivo demonstration of such a high population of CD4 + T cells with a cytotoxic potential. CD4 + and CD8 + T cell responses persisted in the spleen up to 15 days post-infection, ( Figure 1B) . We also observed that T cell activation decreased at 22 days post-infection together with a strong decline of the Granzyme B-expressing CD4 + T cell population ( Figure 1B) .
T cell responses were also investigated in various lymph nodes (LNs) such as mesenteric LNs (MLNs), axillary LNs (ALNs) and inguinal LNs (ILNs). The pattern of cellular immune responses was similar in these different LNs. CD4 + and CD8 + T cell responses were triggered in the different LNs at 8 days post-infection, as illustrated in ALNs ( Figure S1 ). Both, CD4 + and CD8
+ T cells up-regulated the expression of CD25 (not shown) and produced effector molecules such as Granzyme B and/or IFN-γ ( Figure S1 ). In ALNs, 27% of the whole CD4 + T cell population expressed Granzyme B ( Figure S1 ). This population was lower in ILNs and MLNs, representing 5% and 13%, respectively (not shown). From 15 days post-infection onwards, T cell responses in the LNs decreased ( Figure S1 ) and we could not detect any CD4 + Granzyme B + T cell subset, showing that the induction of Granzyme B-expressing CD4 + T cells correlates with the triggering of CD4 + and CD8 + T cell responses.
BALB/c mice have been shown to be more sensitive to Brucella infection than C57BL/6 mice [1] . A large subpopulation of CD4 + T cells expressing Granzyme B was also identified in BALB/c mice infected with Brucella ( Figure S2A ).
Overall, these data suggest that Brucella infection triggers a subset of CD4 + Granzyme B + T cells with a cytotoxic potential. 
Characterization of Granzyme
Bacterial load and IFN-γ secretion during infection
It has been largely described that IFN-γ-mediated T H 1 responses are essential for the clearance of the pathogen [6] . We have therefore measured the amount of IFN-γ in the sera of infected mice. The highest levels were observed at 5 days post-infection and then decreased from 8 days post-infection onwards ( Figure 3A ). Moreover we have observed the secretion of very low levels of TNF-α (not shown). The cytokine expression was also analysed by QRT-PCR in the spleen of 8 and 15 days infected mice. The induction of IFN-γ, IL-6 and Granzyme B was detected (not shown).
We next analyzed the bacterial load in the spleen ( Figure 3B Figure 4B ). We next determined whether the lysis of target cells by Granzyme B + CD4 + T cells is antigen-specific. In order to do so, effector cells from Brucella-infected mice were co-cultured either with macrophages infected with Brucella or with another intracellular bacterium, Mycobacterium avium ( Figure 4C ). Results show that effector cells from mice infected with Brucella efficiently lysed macrophages infected with B. abortus, whereas M. avium-infected macrophages were not affected.
In addition, confocal microscopy shows ( Figure S5 ) that Granzyme B in CD4 + T cells colocalized with Lamp-1, a marker 
Discussion
We identified for the first time a population of murine CD4 + CTLs during virulent Brucella abortus infection in vivo. This population produces high levels of Granzyme B and displays specific cytolytic capacity against infected macrophages. These cells correspond to fully differentiated CD4 + T cells and do not belong to the CD4 + regulatory T cell or to the CD4 + NKT cell subset. The immunophenotypic features of CD4 + CTLs include the expression of CD25, CD44, CD62L and CD43 molecules, as well as the production of IFN-γ. Moreover, cytotoxic CD4 + T cells expressed neither the co-stimulatory molecule CD27 nor the memory T cell marker CD127. The early phase of Brucella infection has been characterized as a T H 1 (producing IFN-γ) type adaptive immune response [1] and CD4 + CTLs may participate in these first steps.
Here we show that at early stages of Brucella infection a heterogeneous effector T cell population including CD8 + CTLs and CD4 + CTLs both expressing high levels of Granzyme B is present in the spleen and LNs, whereas CD4 
Materials and Methods
Ethics statement
Animal experimentation was conducted in strict accordance with good animal practice as defined by the 
Mice and cells
Six weeks old female C57Bl/6 and BALB/c mice from Jackson Laboratory were used. INSERM guidelines have been followed regarding animal experimentation (authorization No. 02875 for mouse experimentation). Animals were killed by cervical dislocation at appropriate times. Cells were isolated from lymphoid organs (spleen and lymph nodes) of infected and non-infected mice using a mix of type I collagenase (Sigma) and DNAse I (Sigma-Aldrich). Isolated cells were stimulated by CD3 antibody for 4 h at 37°C in the presence of BD Golgi Stop (BD Biosciences). The expression of molecular markers, intracellular cytokines and Granzyme B was then evaluated by flow cytometry. Five mice were used for each infection and the representative data is shown. All experiments were carried out at least 3 independent times.
Bacterial infection and replication assays
Virulent B. abortus strain 2308 was used for infection experiments. Brucella was grown in tryptic soy broth (TSB; Sigma-Aldrich). For infection, we inoculated 2 ml of media and bacteria were cultivated for 16 h at 37 °C up to an optical density (OD 600nm ) of approximately 2.0. Groups of 3 six-weekold female mice were intraperitoneally infected with 10 6 CFU of B. abortus 2308. To calculate bacterial multiplication rates, spleens and lymph nodes were aseptically removed and individually homogenized in PBS. Dilutions from these homogenates were seeded on TSA and CFU numbers were determined.
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Flow cytometry
Antibodies used for flow cytometry included PerCP-Cy5.5-CD4, Alexa700-CD8, Pacific blue-CD5, FITC-CD25, PE-CD127, PerCP-Cy5.5-CD27, Alexa700-CD44, PE-Cy7-CD4, FITC-NK1.1 (all from eBiosciences). The Aqua Dead Cell Stain (Invitrogen) was used to stain the dead cells. CD4 and CD8 T cells were fixed and permeabilized with Fixation/ Permeabilization buffers (eBiosciences) following manufacturer's protocol. PE-Cy7-IFN-γ (eBiosciences) and APC-Granzyme B (Invitrogen) antibodies were used for the intracellular labeling of lymphocytes. Isotype matched controls were used appropriately. At least 100,000 events were collected on flow cytometry Canto II (BDBiosciences). Flow cytometry data was analyzed by FlowJo software.
Cytokine measurement
IFN-γ and TNF-α were quantified in the sera of Brucella infected mice (3 per group) by sandwich enzyme-linked immunosorbent assays (ELISA) according to the manufacturer's instruction (eBiosciences).
Cytotoxicity assay
Balb/c mice were infected for 8 days with B. abortus 2308. CD4 + and CD8 + T cells from spleen were then negatively enriched using mouse CD8 and CD4 negative isolation kit (Dynal). CD4 + and CD8 + T cell percentages were determined by flow cytometry, the degree of purification obtained was > 90%. Raw macrophages were infected either with alive or heat killed B. abortus 2308 or alive Mycobacterium avium for 4 h and rinsed twice. Infected or uninfected macrophages were cultured alone (low control) or co-cultured with effector cells at a ratio effector: macrophage of 5:1, 10:1, 30:1 or 50:1 during 4 h. A 100% control of complete macrophage lysis (high control) was obtained by lysing corresponding wells with 1% TritonX-100. Cytotoxicity was determined by analyzing supernatants with the LDH-release assay (Roche Diagnostics) was then performed with the supernatants to determine cytotoxicity. Relative cytotoxicity was calculated as follows: Relative cytotoxicity (%) = [(Effector and target cell mix) -(Effector cells alone) -(low control)]/ (high control -low control)] x 100. The infection of target cells was confirmed by plating.
Confocal fluorescence microscopy
Raw macrophages were seeded on coverslips, infected with B. abortus as described and incubated with CD4 + effector cells from the spleen of a mouse that had been infected with B. abortus for 8 days. After 1 h, samples were fixed in 3.2% formaldehyde in PBS. Residual formaldehyde was quenched by a 20 min incubation in 50 mM NH 4 CL in PBS. Fixed cells were permeabilized in fixation/permeabilization buffer from the Foxp3 / Transcription Factor Staining Buffer Set (eBioscience), rinsed once in permeabilization buffer (PB) of the same kit and blocked for 1h with PB containing 5% BSA. Coverslips were incubated in rabbit anti-LAMP1 at 1:1000 (obtained from obtained from Dr. Minoru Fukuda (La Jolla Cancer Research Foundation)) and anti-GranzymeB-APC at 1:100 (Invitrogen) in PB/5% BSA for 1h, rinsed twice in PB and subsequently stained in anti-rabbit-Cy3 (1:500), anti-CD4-FITC (1:100, Biolegend) and anti-mouse-Cy5 (1:500, Jackson ImmunoResearch) in PB/5% BSA for 1 h. Samples were rinsed twice in PB, once in PBS, once in H 2 O and embedded in ProLongGold (Invitrogen) for analysis with a confocal Leica SP5X microscope.
For cytotoxicity assay, Raw macrophages were seeded onto coverslips and incubated with heat-killed B. abortus 2308 at an MOI of 100 for 4 h. Macrophages were rinsed twice with PBS. CD4 + or CD8 + effector cells isolated as described above were added at an effector:macrophage ratio of 5:1 and cells were incubated for another 4 h before fixation. Antibodies used for immunofluorescence staining were anti-CD8-Alexa488, anti-CD4-Alexa647, anti-F4/80 (all from Biolegend) and anti-ratDyLight549 (Abcam). Cells' nuclei were visualized by embedding samples into Prolong Gold (Invitrogen) containing DAPI. Coverslips were analysed at a Leica SP5X confocal microscope and images processed using the corresponding software LAS AF Lite.
Statistical analysis
All experiments were carried out at least 3 independent times. Statistical analysis was done using two-tailed unpaired Student's t test and all the results correspond to the means +/-standard errors. Differences were considered as significante when P values were <0.05. 
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